Incannex website
WebApr 14, 2024 · Incannex is a clinical stage pharmaceutical development company that is developing unique medicinal cannabis pharmaceutical products and psychedelic medicine therapies for the treatment of obstructive sleep apnoea (OSA), traumatic brain injury (TBI) and concussion, lung inflammation (ARDS, COPD, asthma, bronchitis), rheumatoid …
Incannex website
Did you know?
WebMar 16, 2024 · Incannex is listed on the Australian Stock Exchange (ASX) with stock code “IHL” and has American Depository Shares listed on NASDAQ under code “IXHL”. Website: www.incannex.com.au Investors:... Web1 day ago · Melbourne, Australia, April 14, 2024 - Incannex Healthcare Ltd (Nasdaq: IXHL). (ASX: IHL) ('Incannex' or 'the Company') a pharmaceutical company developing proprietary medicinal cannabinoid products and psychedelic assisted psychotherapies for unmet medical needs is pleased to announce that is has appointed Quest Pharmaceutical …
WebApr 14, 2024 · Website: www.incannex.com.au Investors: [email protected]. Forward-looking statements This press release contains "forward-looking statements" within the meaning of the "safe harbor ... WebAug 17, 2024 · Incannex Healthcare Limited. Mr Joel Latham. Managing Director and Chief Executive Officer. +61 409 840 786. [email protected]. Investor Relations Contact – United States. Alyssa Factor ...
Web1 day ago · Website: www.incannex.com.au Investors: [email protected]. Forward-looking statements This press release contains "forward-looking statements" … WebApr 21, 2024 · Website: www.incannex.com.au Investors: [email protected] Forward-looking statements This press release contains "forward-looking statements" within the meaning …
WebAug 2, 2024 · Incannex Chief Scientific Officer Dr Mark Bleackley said; "Scaling up cGMP manufacture of IHL-216A is an exciting step in the development of our product and represents a critical milestone for ...
WebApr 14, 2024 · MELBOURNE, Australia, April 14, 2024 (GLOBE NEWSWIRE) -- Incannex Healthcare Ltd (Nasdaq: IXHL) (ASX: IHL) (‘Incannex’ or ‘the Company’) a pharmaceutical company developing proprietary medicinal cannabinoid products and psychedelic assisted psychotherapies for unmet medical needs, is pleased to announce that is has appointed … bismarck used appliancesWebFeb 28, 2024 · Incannex is a clinical stage pharmaceutical development company that is developing unique medicinal cannabis pharmaceutical products and psychedelic medicine therapies for the treatment of... bismarck vape shopWebIncannex Healthcare Limited 1,254 followers on LinkedIn. Incannex is a clinical stage pharmaceutical development company that is developing unique medicinal cannabis pharmaceutical products and psychedelic medicine therapies for the treatment of anxiety disorders, obstructive sleep apnoea (OSA), traumatic brain injury (TBI)/concussion, lung … darlington chinese takeawayWebApr 14, 2024 · Website: www.incannex.com.au Investors: [email protected] Forward-looking statements This press release contains "forward-looking statements" within the meaning of the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements are made as of the date they were first … darlington cares facebookWebOct 13, 2024 · Incannex is listed on the Australian Stock Exchange (ASX) with stock code “IHL” and also has American Depository Shares listed on NASDAQ under code “IXHL”. … darlington cinema listingsWebJul 27, 2024 · Incannex Healthcare Limited. Jul 27, 2024, 07:55 ET. MELBOURNE, Australia, July 27, 2024 /PRNewswire/ -- Clinical stage pharmaceutical development company, Incannex Healthcare Limited (ASX: IHL ... bismarck used cars dealershipsWeb1 day ago · Melbourne, Australia, April 14, 2024 - Incannex Healthcare Ltd (Nasdaq: IXHL). (ASX: IHL) ('Incannex' or 'the Company') a pharmaceutical company developing proprietary … darlington christmas store fort wayne indiana